November 13, 2024
Genesis Therapeutics Announces New Equity Investment and Collaboration with NVIDIA to Optimize Key Computational Methods for AI-powered Drug Discovery
Business Wire
Join Us
Opportunities in AI and Physics Research
Our molecular AI research team is pioneering new frameworks for drug discovery, at the intersection of multi-dimensional ML models and physical simulation. See opportunities in software engineering, machine learning and computation chemistry.
Software Engineering
Machine Learning
Computational Chemistry
